ZA903142B - Canine corona virus vaccine - Google Patents

Canine corona virus vaccine

Info

Publication number
ZA903142B
ZA903142B ZA903142A ZA903142A ZA903142B ZA 903142 B ZA903142 B ZA 903142B ZA 903142 A ZA903142 A ZA 903142A ZA 903142 A ZA903142 A ZA 903142A ZA 903142 B ZA903142 B ZA 903142B
Authority
ZA
South Africa
Prior art keywords
virus vaccine
corona virus
canine corona
canine
vaccine
Prior art date
Application number
ZA903142A
Other languages
English (en)
Inventor
William Baxendale
Baxendale William
William Stuart Kenned Chalmers
Stuart Kennedy Chalmer William
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA903142B publication Critical patent/ZA903142B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA903142A 1989-05-03 1990-04-25 Canine corona virus vaccine ZA903142B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89304441 1989-05-03

Publications (1)

Publication Number Publication Date
ZA903142B true ZA903142B (en) 1991-02-27

Family

ID=8202669

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA903142A ZA903142B (en) 1989-05-03 1990-04-25 Canine corona virus vaccine

Country Status (12)

Country Link
US (2) US5232694A (ko)
EP (1) EP0396193B1 (ko)
JP (1) JP2892767B2 (ko)
KR (1) KR0142081B1 (ko)
AU (1) AU630186B2 (ko)
CA (1) CA2015828C (ko)
DE (1) DE69014974T2 (ko)
DK (1) DK0396193T3 (ko)
ES (1) ES2068322T3 (ko)
HU (1) HU214739B (ko)
NZ (1) NZ233509A (ko)
ZA (1) ZA903142B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
AU5530498A (en) * 1996-12-18 1998-07-15 Synbiotics Corporation A specific diagnostic for antibodies to feline infectious peritonitis virus
AU2005200757A1 (en) * 2005-02-21 2006-09-07 Peter Henry Scott An Insect Attractant Composition and Trap Containing Same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
EP0138242A1 (en) * 1983-09-07 1985-04-24 Duphar International Research B.V Method of preparing DNA complementary to the genome of coronaviruses
AU7961487A (en) * 1986-08-22 1988-03-08 University Of Texas System, The Human enteric coronavirus
US4904468A (en) * 1987-06-08 1990-02-27 Norden Laboratories, Inc. Canine coronavirus vaccine

Also Published As

Publication number Publication date
EP0396193A1 (en) 1990-11-07
JP2892767B2 (ja) 1999-05-17
NZ233509A (en) 1992-05-26
DE69014974T2 (de) 1995-05-18
KR0142081B1 (ko) 1998-06-01
EP0396193B1 (en) 1994-12-14
KR900017611A (ko) 1990-12-19
DE69014974D1 (de) 1995-01-26
US5464621A (en) 1995-11-07
ES2068322T3 (es) 1995-04-16
HUT56287A (en) 1991-08-28
CA2015828C (en) 1999-07-13
HU214739B (hu) 2000-03-28
HU902644D0 (en) 1990-09-28
CA2015828A1 (en) 1990-11-03
US5232694A (en) 1993-08-03
JPH02295934A (ja) 1990-12-06
AU5474190A (en) 1990-11-08
AU630186B2 (en) 1992-10-22
DK0396193T3 (da) 1995-02-27

Similar Documents

Publication Publication Date Title
HU9201966D0 (en) An improved vaccine of meningococcus-polysaccharide conjunction
EP0391997A4 (en) Vaccine
HU913433D0 (en) Chicken anemy virus vaccine and diagnostics
EP0210931A3 (en) Vaccine against varicella-zoster virus
GB9210337D0 (en) Feline leukaemia virus vaccine
GB8921470D0 (en) Vaccines
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
ZA903142B (en) Canine corona virus vaccine
ZW19090A1 (en) Malaria vaccine
ZA908189B (en) Infectious bronchitis virus vaccine
EP0769952A4 (en) VACCINE AGAINST CHICKEN INFECTIOUS ANEMIA VIRUS
HU9203976D0 (en) Vaccine based on modified herpes virus
ZA903327B (en) Malaria vaccine
ZA896372B (en) Vaccine
BR9007246A (pt) Preparacao de vacinas
ZA924670B (en) Ccv vaccine
IL90421A0 (en) Influenza vaccine
AU614735C (en) Canine distemper virus vaccine
GB8509343D0 (en) Virus vaccine
ZA883365B (en) Newcastle disease virus vaccine and method for the application thereof
GR3003377T3 (en) Virus vaccine
GB8712042D0 (en) Virus & vaccine
GB8922651D0 (en) Vaccine
IL86573A0 (en) Influenza vaccine
IE892907L (en) Viral vaccines